Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05297032 · ClinicalTrials.gov registry record · NA
Effects of Quercetin on Metabolic Health
A NA study, sponsored by Thorne HealthTech.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05297032 is a NA study that was terminated before completion, run by Thorne HealthTech. The registered enrollment target is 5 participants.
The verdict
NCT05297032, a NA study, was terminated before completion, sponsored by Thorne HealthTech.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Quercetin is a natural flavonoid compound widely found in vegetables, fruits, and nuts. It has a long history of use as a dietary supplement. This study aims to assess results from a computational model suggesting that quercetin may offer novel benefits to metabolic health. Participants will take quercetin (as Quercetin Phytosome, a proprietary formulation with enhanced absorption properties) for 90 days while keeping lifestyle habits consistent throughout to estimate net effects of quercetin as much as possible. Blood samples will be collected at the beginning and end of the study to assess the effects of quercetin supplementation on metabolic health metrics such as LDL cholesterol, blood sugar, liver, kidney and immune function and calculated metabolic age. In addition, questionnaires will be completed to ensure compliance with study requirements and assess potential quercetin benefits in the participants' quality of life. This work will provide a proof-of-concept from a computational model of nutraceutical compounds and proposes a new application of quercetin in support of healthy human metabolism.
Interventions
- DIETARY_SUPPLEMENT Quercetin Phytosome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-03-24 |
| Est. Completion | 2022-09-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05297032
The ClinicalTrials.gov registry entry for NCT05297032 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thorne HealthTech, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quercetin Phytosome is the first listed.
NCT05297032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05297032 about?
NCT05297032 is a clinical study titled "Effects of Quercetin on Metabolic Health". Quercetin is a natural flavonoid compound widely found in vegetables, fruits, and nuts. It has a long history of use as a dietary supplement. This study aims to assess results from a computational model suggesting that quercetin may offer novel benefits to metabolic health. Participants will take qu...
What is the current status of trial NCT05297032?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-03-24. Estimated completion is 2022-09-02.
What interventions are being tested in trial NCT05297032?
The interventions under investigation include: Quercetin Phytosome (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05297032?
This trial is sponsored by Thorne HealthTech, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.